V2X, Inc.
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders' Equity
| Common Stock Issued · Treasury Stock · Additional Paid-in Capital · Retained Earnings · Accumulated Other Comprehensive Loss · Total Shareholders' Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In thousands) · Shares · Amount · Shares · Amount | ||||||||
| Balance at December 31, 2022 | 30,470 | $305 | — | $— | $748,877 | $253,424 | $(5,527) | $997,079 |
| Net loss | — | — | — | — | — | (22,573) | — | (22,573) |
| Foreign currency translation adjustments | — | — | — | — | — | — | 3,066 | 3,066 |
| Unrealized loss on cash flow hedge | — | — | — | — | — | — | (226) | (226) |
| Employee stock awards and stock options | 722 | 7 | — | — | 27 | — | — | 34 |
| Taxes withheld on stock compensation awards | — | — | — | — | (18,036) | — | — | (18,036) |
| Stock-based compensation | — | — | — | — | 31,456 | — | — | 31,456 |
| Balance at December 31, 2023 | 31,192 | $312 | — | $— | $762,324 | $230,851 | $(2,687) | $990,800 |
| Net income | — | — | — | — | — | 34,684 | — | 34,684 |
| Foreign currency translation adjustments | — | — | — | — | — | — | (10,934) | (10,934) |
| Unrealized gain on cash flow hedge | — | — | — | — | — | — | 4,203 | 4,203 |
| Employee stock awards and stock options | 368 | 4 | — | — | 150 | — | — | 154 |
| Taxes withheld on stock compensation awards | — | — | — | — | (8,138) | — | — | (8,138) |
| Stock-based compensation | — | — | — | — | 15,383 | — | — | 15,383 |
| Balance at December 31, 2024 | 31,560 | $316 | — | $— | $769,719 | $265,535 | $(9,418) | $1,026,152 |
| Net income | — | — | — | — | — | 77,882 | — | 77,882 |
| Foreign currency translation adjustments | — | — | — | — | — | — | 6,128 | 6,128 |
| Unrealized loss on cash flow hedge | — | — | — | — | — | — | (4,618) | (4,618) |
| Employee stock awards and stock options | 175 | 1 | — | — | 556 | — | — | 557 |
| Taxes withheld on stock compensation awards | — | — | — | — | (3,115) | — | — | (3,115) |
| Stock-based compensation | — | — | — | — | 11,924 | — | — | 11,924 |
| Treasury Stock | — | — | (564) | (30,274) | — | — | — | (30,274) |
| Balance at December 31, 2025 | 31,735 | $317 | (564) | $(30,274) | $779,084 | $343,417 | $(7,908) | $1,084,636 |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business and Basis of Presentation
Business
V2X, Inc. is a leading provider of critical mission solutions primarily to defense customers globally. The Company operates asone segment and offers a broad suite of capabilities including multi-domain high impact readiness, integrated supply chain management, mission solutions, and platform renewal and modernization to national security, defense, civilian and international customers.
Unless the context otherwise requires or unless stated otherwise, references in these notes to "V2X", "we," "us," "our," "the Company" and "our Company" refer to V2X, Inc. and all of its consolidated subsidiaries, taken together as a whole.
Equity Investment
In 2011, the Company entered into a joint venture agreement with APTIM Federal Services LLC (formerly Shaw Environmental & Infrastructure, Inc.). Pursuant to the joint venture agreement, High Desert Support Services, LLC (HDSS) was established to pursue and perform work on the Ft. Irwin Installation Support Services Contract, which was awarded to HDSS in October 2012. In 2018, the Company entered into a joint venture agreement with J&J Maintenance. Pursuant to the joint venture agreement, J&J Facilities Support, LLC (J&J) was established to pursue and perform work on various U.S. government contracts. In 2020, the Company entered into a joint venture agreement with Kuwait Resources House for Human Resources Management and Services Company. Pursuant to the joint venture agreement, ServCore Resources and Services Solutions, LLC. (ServCore) was established to operate and manage labor and life support services outside of the continental U.S. at designated locations serviced by V2X and others around the world. In February 2022, the Company and Permagreen Grønland formed Inuksuk A/S (Inuksuk), a corporation in Greenland to bid for certain contracts in Greenland.
The Company accounts for its investments in HDSS, J&J, ServCore, and Inuksuk under the equity method and has the ability to exercise significant influence over, but does not hold a controlling interest in, these entities. The Company's proportionate 25%,50%,40%, and 49% shares, respectively, of income or losses from HDSS, J&J, ServCore and Inuksuk are recorded in selling, general and administrative expenses in the Consolidated Statements of Income (Loss). These investments are recorded in other non-current assets in the Consolidated Balance Sheets.
When cash distributions are received by the Company from its equity method investments, the cash distribution is compared to cumulative earnings and cumulative cash distributions. Cash distributions received are recorded as a return on investment in operating cash flows within the Consolidated Statements of Cash Flows to the extent cumulative cash distributions are less than cumulative earnings. Any cash distributions in excess of cumulative earnings are recorded as a return of investment in investing cash flows within the Consolidated Statements of Cash Flows. As of December 31, 2025 and December 31, 2024, the Company's combined investment balance was $10.8 million and $8.6 million, respectively, included in other non-current assets on the Company's Consolidated Balance Sheets. The Company's proportionate share of income from equity method investments was$8.0 million, $9.9 million, and $4.0 million for the years ended December 31, 2025, 2024, and 2023, respectively.
Summary of Significant Accounting Policies
Principles of Consolidation
V2X consolidates companies in which it has a controlling financial interest. All intercompany transactions and balances have been eliminated.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, revenue recognition; income taxes; fair value and impairment of goodwill and intangible assets. Actual results could differ from these estimates.
Segment Information
Management has concluded that the Company operates asone segment based upon the information used by the chief operating decision maker (CODM) in evaluating the performance of the Company’s business and allocating resources and capital. Although we perform services worldwide, the substantial majority of our revenue for the years ended December 31, 2025, 2024 and 2023 was derived from the U.S. government. Refer to Note 18, Segment Information, for additional information.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current year presentation. These reclassifications had no material impact on the results of operations, financial position, or changes in shareholders' equity.
As a defense contractor engaging in long-term contracts, the substantial majority of our revenue is derived from long-term service contracts. The unit of account for revenue in ASC Topic 606, Revenue from Contracts with Customers (Topic 606) is a performance obligation. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. To determine the proper revenue recognition method, consideration is given as to whether a single contract should be accounted for as more than one performance obligation. For most of our contracts, the customer contracts with us to perform an integrated set of tasks and deliverables as a single service solution, whereby each service is not separately identifiable from other promises in the contract and therefore is not distinct. As a result, when this integrated set of tasks exists, the contract is accounted for as one performance obligation. The vast majority of our contracts have a single performance obligation. Unexercised contract options and IDIQ contracts are considered to be separate performance obligations when the option or IDIQ task order is exercised or awarded. The majority of our performance obligations are satisfied over time as services are provided throughout the contract term, with revenue recognized over time using the input method (e.g., costs incurred to date relative to total estimated costs at completion) to measure progress. Our over time recognition is reinforced by the fact that our customers simultaneously receive and consume the benefits of our services as they are performed. For most U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. This continuous transfer of control requires that we track progress towards completion of performance obligations in order to measure and recognize revenue.
Accounting for contracts and programs involves the use of various techniques to estimate total contract revenue and costs. For contracts, we estimate the profit on a contract as the difference between the total estimated revenue and expected costs to complete a contract and recognize that profit over the life of the contract. Contract estimates are based on various assumptions to project the outcome of future events. These assumptions include labor productivity and availability; the complexity of the services being performed; the cost and availability of materials; the performance of subcontractors; and negotiations with the customer on contract modifications. When the estimates of total costs to be incurred on a contract exceed total estimates of the transaction price, a provision for the entire loss is determined at a contract level and is recognized in the period in which the loss was determined.
The nature of our contracts gives rise to several types of variable consideration, including award and incentive fees, inspection of supplies and services, undefinitized change orders, and fluctuation in allowable indirect reimbursable costs. We include award or incentive fees in the estimated transaction price when there is certainty and a basis to reasonably estimate the amount of the fee. These estimates are based on historical award experience, anticipated performance and our best judgment at the time. The inspection of supplies and services is a factor because the U.S. government can reduce the transaction price if we do not perform the services in compliance with contract requirements. Variable consideration associated with undefinitized change orders is included to the extent related estimated costs have been included in the expected costs to complete a contract. The fluctuation of allowable indirect reimbursable costs is a factor because the U.S. government has the right to review our accounting records and retroactively adjust the reimbursable rate. Any prior adjustments are reflected in the U.S. government reserve amounts recorded in our financial statements. We estimate variable consideration at the most likely amount that we expect to be entitled to receive, which is included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. Refer to Note 14, Commitments and Contingencies, for additional information regarding U.S. government reserve amounts.
As a significant change in one or more of these estimates could affect the profitability of our contracts, we review and update our contract estimates regularly. We recognize adjustments in estimated profit on executed contracts cumulatively. The impact of the adjustments on profit recorded to date is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance are recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, we recognize the total loss in the quarter it is identified.
Contracts are often modified to account for changes in contract specifications and requirements. If the modification either creates new enforceable rights and obligations or changes the existing enforceable rights and obligations, the modification will be treated as a separate contract. Our contract modifications, except for those to exercise option years, have historically not been distinct from the existing contract and have been accounted for as if they were part of that existing contract.
The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets. Amounts are billed as work progresses in accordance with agreed-upon contractual terms at periodic intervals (e.g., biweekly or monthly). Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, we may receive advances or deposits from our customers, before revenue is recognized, resulting in contract liabilities. These advance billings and payments are not considered significant financing components because they are frequently intended to fund current operating expenses under the contract. These assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period.
Restricted Cash
As of December 31, 2025 the Company had total cash, cash equivalents and restricted cash of $369.0 million which included $3.0 million of restricted cash. The Company's restricted cash was $3.1 million as of December 31, 2024.
Cloud Computing Arrangements (CCA)
The Company capitalizes implementation costs associated with its CCA consistent with costs capitalized for internal-use software. Capitalized CCA implementation costs are included in prepaid expenses and other current assets and other non-current assets on the Company's Consolidated Balance Sheets. The CCA implementation costs are amortized over the term of the related hosting agreement, including renewal periods that are reasonably certain to be exercised. Amortization expense of CCA implementation costs is included in cost of revenue on the Company's Consolidated Statements of Income (Loss). The CCA implementation costs are included within operating activities on the Company's Consolidated Statements of Cash Flows.
As of December 31, 2025 and 2024, the Company had total capitalized CCA implementation costs, net of accumulated amortization, of $25.1 million and $29.2 million, respectively, included in prepaid expenses and other current assets and other non-current assets on the Company's Consolidated Balance Sheets.
Receivables
Receivables include amounts billed and currently due from customers, amounts unbilled, certain estimated contract change amounts, estimates related to expected award fees, claims or REAs in negotiation that are probable of recovery, and amounts retained by the customer pending contract completion. Unbilled receivables are classified as current assets based on our contract operating cycle. Substantially all billed receivables are due from the U.S. government, either directly as prime contractor to the U.S. government or as subcontractor to another prime contractor to the U.S. government. Because the Company’s billed receivables are with the U.S. government, the Company does not believe it has a material credit risk exposure.
Inventory, Net
Inventory, net is substantially comprised of finished goods inventory and is valued at the lower of cost or net realizable value, generally using the average cost method. We establish provisions for excess and obsolete inventories after evaluation of historical sales, current economic trends, forecasted sales, and current inventory levels.
Earnings (Loss) Per Share
We compute earnings (loss) per common share on the basis of the weighted average number of common shares, and, where dilutive, common share equivalents, outstanding during the indicated periods.
Stock-Based Compensation
We recognize stock-based compensation expense based on the grant date fair values of the equity instruments issued or on the fair values of the liabilities incurred. The expense is recognized primarily within selling, general and administrative expenses over the requisite service periods of the awards, which are generally equivalent to the vesting terms.
Property, Plant and Equipment, Net
Property, plant and equipment, net is stated at cost less accumulated depreciation. Major improvements are capitalized at cost while expenditures for maintenance, repairs and minor improvements are expensed. For asset sales or retirements, the assets and related accumulated depreciation and amortization are eliminated from the accounts and any resulting gain or loss is reflected in operating income.
Depreciation and amortization are generally computed using either an accelerated or straight-line method and is based on estimated useful lives or lease terms as follows:
| Years | |
|---|---|
| Buildings and improvements | 3 – 40 |
| Machinery, equipment and vehicles | 3 – 10 |
| Office furniture and equipment, computers and software | 3 – 7 |
Long-Lived Asset Impairment
Long-lived assets are tested for impairment whenever events or changes in circumstances indicate their carrying value may not be recoverable. We assess the recoverability of long-lived assets based on the undiscounted future cash flow the assets are expected to generate. When carrying value exceeds the undiscounted future cash flow, an impairment is recorded when the carrying value of the asset exceeds its estimated fair value based on a discounted cash flow approach or, when available and appropriate, comparable market values.
Goodwill
Goodwill represents purchase consideration paid in a business combination that exceeds the fair values assigned to the net assets of acquired businesses. Goodwill is not amortized but instead is tested for impairment annually (or more frequently if impairment indicators arise, such as changes to the reporting unit structure or significant adverse changes in the business climate). We conduct our annual impairment testing on the first day of the Company's fourth fiscal quarter.
We assess goodwill for impairment initially using qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying amount. Qualitative factors include macroeconomic, industry and market conditions, cost factors, overall financial performance, relevant entity-specific events, factors affecting the reporting unit, and share price.
If we conclude, based on our assessment of relevant events, facts and circumstances, that it is more likely than not that a reporting unit’s carrying value is greater than its fair value, then a quantitative analysis will be performed to determine whether there is any impairment. Because the Company has only one reporting unit, a market capitalization calculation can be performed as the first step of the quantitative assessment by comparing the Company’s book value of equity to market capitalization. If the market capitalization is greater than the book value of equity, goodwill is deemed not to be impaired, and no further testing is required. If the market capitalization is less than the book value of equity, then the Company must take an additional step to determine the fair value of the reporting unit by using an income approach and/or market approach, which is then compared to the carrying value, including goodwill, to determine any potential impairment.
Intangible Assets
We recognize acquired intangible assets apart from goodwill whenever the intangible assets arise from contractual or other legal rights, or whenever they can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their estimated useful lives unless the estimated useful life is determined to be indefinite. Finite lived intangible assets are being amortized over useful lives offour totwelve years. The straight-line method of amortization is used as it has been determined to approximate the use pattern of the assets.
Leases
In accordance with ASC Topic 842, Leases (ASC Topic 842), operating leases are included on our Consolidated Balance Sheets as right-of-use (ROU) assets, other accrued liabilities and operating lease liabilities.
ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Because most of our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The lease ROU assets also include any prepaid lease payments and exclude lease incentives. Many of our leases includeone or more options to renew or terminate the lease, solely at our discretion. Such options are factored into the lease term when it is reasonably certain that we will exercise the option. Lease expense for lease payments is recognized on a straight-line basis over the term of the lease.
As allowed under ASC Topic 842, the Company elected the package of practical expedients permitted under the transition guidance which allowed the Company to carry forward the historical lease classification, assessment of whether a contract was or contained a lease and assessment of initial direct costs. In addition, we have made policy elections to apply the short-term leases practical expedient, whereby leases with a term of 12 months or less are not recorded on our balance sheet, and the practical expedient to not separate lease components from non-lease components. The latter expedient is applied to all of our leases. We did not elect to apply the hindsight practical expedient in determining lease terms and assessing impairment of ROU assets. See Note 11, Leases, for further information.
Income Taxes
We determine the provision or benefit for income taxes using the asset and liability approach. Under this approach, deferred income taxes represent the expected future tax consequences of temporary differences between the carrying amounts and tax basis of assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. In assessing the need for a valuation allowance, we look to the future reversal of existing taxable temporary differences, taxable income in carryback years, the feasibility of tax planning strategies, and estimated future taxable income. The valuation allowance can be affected by changes to tax laws, changes to statutory tax rates and changes to future taxable income estimates. See Note 12, Income Taxes, for further information.
Commitments and Contingencies
We record accruals for commitments and loss contingencies when they are probable of occurrence and the amounts can be reasonably estimated. In addition, legal fees are accrued for cases where a loss is probable and the related fees can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount of loss. We review these accruals quarterly and adjust the accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other updated information. See Note 14, Commitments and Contingencies, for further information.
Derivative Instruments
Derivative instruments are recognized as either an asset or liability at fair value in our Consolidated Balance Sheets and are classified as current or long-term based on the scheduled maturity of the instrument. Our derivative instruments have been formally designated and qualify as part of a cash flow hedging relationship under applicable accounting standards.
The interest rate derivative instruments are adjusted to fair value through accumulated other comprehensive loss. If we were to determine that a derivative was no longer highly effective as a hedge, we would discontinue the hedge accounting prospectively. Gains or losses would be immediately reclassified from accumulated other comprehensive loss to earnings relating to hedged forecasted transactions that are no longer probable of occurring. Gains or losses relating to terminations of effective cash flow hedges in which the forecasted transactions would still be probable of occurring would be deferred and recognized consistent with the income or loss recognition of the underlying hedged item.
Refer to Note 10, Derivative Instruments, for additional information regarding our derivative activities.
Fair Value Measurements
We determine fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In measuring fair value, a fair value hierarchy is applied which categorizes and prioritizes the inputs used to estimate fair value into three levels. The fair value hierarchy is based on maximizing the use of observable inputs and minimizing the use of unobservable inputs when measuring fair value. Classification within the fair value hierarchy is based on the lowest level input that is significant to the fair value measurement. There are three levels of the fair value hierarchy. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are other than quoted prices included within level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices (in nonactive markets or in active markets for similar assets or liabilities), inputs other than quoted prices that are observable, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 inputs are unobservable inputs for the assets or liabilities.
Foreign Currency Translation
The financial statements of programs for which the functional currency is not the U.S. dollar are translated into U.S. dollars. Balance sheet accounts are translated at the exchange rate in effect at the end of each period; income statement accounts are translated at the average rates of exchange prevailing during the period. Gains and losses on foreign currency translations are recorded as translation adjustments to other comprehensive income (loss). Net gains or losses from foreign currency transactions are reported in selling, general and administrative expenses and have historically been insignificant.
NOTE 2
RECENT ACCOUNTING STANDARDS UPDATES
Accounting Standards Updates Issued but Not Yet Adopted
In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03 Expense Disaggregation Disclosures (Subtopic 220-40), as amended by ASU No. 2025-01 Expense Disaggregation Disclosures (Subtopic 22-40): Clarifying the Effective Date, to require public business entities (PBEs) to disclose disaggregated information about expenses to help investors better understand an entity's performance, better assess the entity's prospects for future cash flows, and compare an entity's performance over time and with that of other entities. The amendments in this ASU are effective for PBEs for annual reporting periods beginning after December 15, 2026, and interim periods with annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of adoption of this standard on its consolidated financial statements.
In September 2025, the FASB issued ASU No. 2025-06 Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, to remove all references to prescriptive and sequential software development stages throughout Subtopic 350-40 to better align the accounting for software costs with how software is developed. The amendments in this ASU are effective for all entities for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of adoption of this standard on its consolidated financial statements.
Accounting Standards Updates Adopted
In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740) to improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information. ASU No. 2023-09 requires a PBE to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received disaggregated by federal, state/local, and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. The Company retrospectively adopted the new standard effective December 31, 2025. The adoption of this ASU affects only the Company's disclosures, with no impacts to its financial condition, results of operations and cash flow.
NOTE 3
REVENUE
Remaining Performance Obligations
Remaining performance obligations represent firm orders by the customer and excludes potential orders under IDIQ contracts, unexercised contract options and contracts awarded to us that are being protested by competitors with the U.S. Government Accountability Office (GAO) or in the U.S. Court of Federal Claims (COFC) for which a stop work order has been received by the Company. The level of order activity related to programs can be affected by the timing of government funding authorizations and their project evaluation cycles. Year-over-year comparisons could, at times, be impacted by these factors, among others.
The Company's contracts are multi-year contracts and typically include an initial period ofone year or less with annualone-year (or less) option periods. The number of option periods varies by contract, and there is no guarantee that an option period will be exercised. The right to exercise an option period is at the sole discretion of the U.S. government when we are the prime contractor or of the prime contractor when we are a subcontractor. We expect to recognize a substantial portion of our performance obligations as revenue within the next 12 months. However, the U.S. government or the prime contractor may cancel any contract at any time through a termination for convenience or for cause. Substantially all of our contracts have terms that would permit us to recover all or a portion of our incurred costs and fees for work performed in the event of a termination for convenience.
Remaining performance obligations as of December 31, 2025 and December 31, 2024 are presented in the following table:
| As of December 31, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Performance Obligations | $3,375 | $3,483 |
As of December 31, 2025, we expect to recognize approximately 75% of the remaining performance obligations as revenue in 2026 and the majority of the remainder of the balance as revenue in 2027 and 2028.
Contract Estimates
The impact of adjustments in contract estimates on our operating income can be reflected in either revenue or cost of revenue. Cumulative adjustments for the years ended December 31, 2025, 2024 and 2023 increased operating income by $19.2 million, $24.8 million and $22.7 million, respectively.
For the years ended December 31, 2025, 2024, and 2023 the net adjustments to operating income increased revenue by $32.6 million, $29.1 million, and $38.1 million, respectively.
Revenue by Category
Generally, the sales price elements for our contracts are cost-plus, cost-reimbursable, firm-fixed-price and time-and-materials, all of which are commonly identified with a single contract. On a cost-plus contract, we are paid our allowable incurred costs plus a profit, which can be fixed or variable depending on the contract’s fee arrangement, up to funding levels predetermined by our customers.
On cost-plus contracts, we do not bear the risks of unexpected cost overruns, provided that we do not incur costs that exceed the predetermined funded amounts. Most of our cost-plus contracts also contain a firm-fixed-price element. Cost-plus contracts with award and incentive fee provisions are our primary variable contract fee arrangement. Award fees provide for a fee based on actual performance relative to contractually specified performance criteria. Incentive fees provide for a fee based on the relationship between total allowable and target cost.
Most of our contracts include a cost-reimbursable element to capture costs of consumable materials required for the program. Typically, these costs do not bear fees.
On a firm-fixed-price contract, we agree to perform the contractual statement of work for a predetermined contract price. A firm-fixed-price contract typically offers higher profit margin potential than a cost-plus contract, which is commensurate with the greater levels of risk we assume on a firm-fixed-price contract. Although a firm-fixed-price contract generally permits us to retain profits if the total actual contract costs are less than the estimated contract costs, we bear the risk that increased or unexpected costs may reduce our profit or cause us to sustain losses on the contract. Although the overall scope of work required under the contract may not change, profit may be adjusted as experience is gained and as efficiencies are realized or costs are incurred.
On a time-and-materials contract, we are reimbursed for labor at fixed hourly rates and generally reimbursed separately for allowable materials, costs and expenses at cost. For this contract type, we bear the risk that our labor costs and allocable indirect expenses are greater than the fixed hourly rate defined within the contract.
Revenue by contract type is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Cost-plus and cost-reimbursable | $2,744,753 | $2,531,792 | $2,209,241 |
| Firm-fixed-price | 1,609,027 | 1,675,603 | 1,626,262 |
| Time-and-materials | 126,258 | 114,760 | 127,623 |
| Total revenue | $4,480,038 | $4,322,155 | $3,963,126 |
Revenue by geographic region in which the contract is performed is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| United States | $2,609,257 | $2,388,598 | $2,286,052 |
| Middle East | 1,351,318 | 1,399,436 | 1,193,598 |
| Asia | 313,024 | 326,961 | 264,346 |
| Europe | 206,439 | 207,160 | 219,130 |
| Total revenue | $4,480,038 | $4,322,155 | $3,963,126 |
Revenue by contract relationship is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Prime contractor | $4,239,080 | $4,049,543 | $3,726,199 |
| Subcontractor | 240,958 | 272,612 | 236,927 |
| Total revenue | $4,480,038 | $4,322,155 | $3,963,126 |
Revenue by customer is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Army | $1,828,977 | $1,837,843 | $1,633,525 |
| Navy | 1,479,815 | 1,441,355 | 1,233,463 |
| Air Force | 570,663 | 481,265 | 538,698 |
| Other | 600,583 | 561,692 | 557,440 |
| Total revenue | $4,480,038 | $4,322,155 | $3,963,126 |
Contract Balances
The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets. Amounts are billed as work progresses in accordance with agreed-upon contractual terms at periodic intervals (e.g., biweekly or monthly). Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. However, we may receive advances or deposits from our customers, before revenue is recognized, resulting in contract liabilities. These advance billings and payments are not considered significant financing components because they are frequently intended to ensure that both parties are in conformance with the primary contract terms. These assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period.
As of January 1, 2024, we had contract assets of $561.9 million. As of December 31, 2025 and 2024, we had contract assets of $637.2 million and $620.5 million, respectively. Contract assets primarily consist of unbilled receivables which represent rights to consideration for work completed but not billed as of the reporting date. The balance of unbilled receivables consists of costs and fees that are: (i) billable immediately; (ii) billable on contract completion; or (iii) billable upon other specified events, such as the resolution of a REA. Refer to Note 4, Receivables, for additional information regarding the composition of our receivables balances. As of January 1, 2024, we had contract liabilities of $109.6 million. As of December 31, 2025 and 2024, we had contract liabilities of $109.4 million and $98.7 million, respectively, included in other accrued liabilities in the Consolidated Balance Sheets.
NOTE 4
RECEIVABLES
Receivables were comprised of the following:
| As of December 31, | ||
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Billed receivables | $87,089 | $77,982 |
| Unbilled receivables (contract assets) | 637,195 | 620,536 |
| Other | 14,638 | 11,550 |
| Total receivables | $738,922 | $710,068 |
As of December 31, 2025 and 2024, substantially all billed receivables were due from the U.S. government, either directly as prime contractor to the U.S. government or as subcontractor to another prime contractor to the U.S. government. Because the Company’s billed receivables are with the U.S. government, the Company does not believe it has a material credit risk exposure.
Unbilled receivables are contract assets that represent revenue recognized on long-term contracts in excess of amounts billed as of the balance sheet date. We expect to bill customers for most of the December 31, 2025 contract assets during 2026. Changes in the balance of receivables are primarily due to the timing differences between performance and customers' payments.
NOTE 5
EARNINGS (LOSS) PER SHARE
Basic earnings per share (EPS) is computed by dividing net income, or loss, by the weighted average number of common shares outstanding for the period. Diluted EPS reflects potential dilution that could occur if securities to issue common stock were exercised or converted into common stock. Diluted EPS includes the dilutive effect of stock-based compensation outstanding after application of the treasury stock method.
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands, except per share data) | 2025 | 2024 | 2023 |
| Net income (loss) | $77,882 | $34,684 | $(22,573) |
| Weighted average common shares outstanding | 31,559 | 31,485 | 31,084 |
| Add: Dilutive impact of stock options | 14 | 19 | — |
| Add: Dilutive impact of restricted stock units and performance share units | 247 | 463 | — |
| Diluted weighted average common shares outstanding | 31,820 | 31,967 | 31,084 |
| Earnings (loss) per share | |||
| Basic | $2.47 | $1.10 | $(0.73) |
| Diluted | $2.45 | $1.08 | $(0.73) |
The following table summarizes the weighted average of anti-dilutive securities excluded from the diluted EPS calculation.
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Anti-dilutive restricted stock units and performance share units | 4 | 20 | 4 |
| Total | 4 | 20 | 4 |
NOTE 6
PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net consisted of the following:
| As of December 31, | ||
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Land, buildings and improvements | $30,113 | $35,959 |
| Machinery, equipment and vehicles | 54,916 | 49,350 |
| Office furniture and equipment, computers and software | 57,684 | 53,017 |
| Property, plant and equipment, gross | 142,713 | 138,326 |
| Less: accumulated depreciation and amortization | (90,330) | (76,325) |
| Property, plant and equipment, net | $52,383 | $62,001 |
Depreciation expense of property, plant and equipment was $17.0 million, $20.7 million and $22.4 million for the years ended December 31, 2025, 2024, and 2023, respectively.
NOTE 7
GOODWILL AND INTANGIBLE ASSETS
The Company tests goodwill for impairment on the first day of the Company's fourth fiscal quarter each year, or more frequently should circumstances change or events occur that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The annual qualitative and quantitative assessment tests performed in the three years ended December 31, 2025 indicated there wasno goodwill impairment.
There wasno change in the net carrying amount of goodwill as of December 31, 2024. The change in the net carrying amount of goodwill as of December 31, 2025 is as follows (in thousands):
| Balance at December 31, 2024 | $1,656,926 |
|---|---|
| Acquisition | 20,228 |
| Balance at December 31, 2025 | $1,677,154 |
Other identifiable intangible assets consist of the following:
| As of December 31, 2025 | As of December 31, 2024 | |||||
|---|---|---|---|---|---|---|
| (In thousands) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount |
| Contract backlogs and recompetes | $395,800 | $(287,235) | $108,565 | $393,300 | $(210,084) | $183,216 |
| Customer contracts | 182,705 | (51,510) | 131,195 | 177,722 | (37,870) | 139,852 |
| Trade names and other | 1,100 | (1,100) | — | 1,260 | (1,260) | — |
| Total intangible assets | $579,605 | $(339,845) | $239,760 | $572,282 | $(249,214) | $323,068 |
Intangible amortization expense was approximately $90.6 million, $90.8 million, and $90.4 million for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025, the weighted-average intangible asset amortization period was 6.8 years.
The estimated future annual amortization expense for intangible assets is as follows:
| (In thousands) | Amortization |
|---|---|
| 2026 | $91,785 |
| 2027 | 21,024 |
| 2028 | 18,522 |
| 2029 | 17,444 |
| 2030 | 17,358 |
| After 2030 | 73,627 |
| Total | $239,760 |
NOTE 8
COMPOSITION OF CERTAIN FINANCIAL STATEMENT CAPTIONS
The following tables present financial information underlying certain balance sheet captions.
Prepaid expenses and other current assets
Prepaid expenses and other current assets were comprised of the following:
| As of December 31, | ||
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Prepaid expenses | $48,895 | $43,338 |
| Inventory, net | 45,854 | 50,894 |
| Prepaid taxes | 9,427 | 8,236 |
| Other | 22,926 | 21,613 |
| Total | $127,102 | $124,081 |
Compensation and other employee benefits
Compensation and other employee benefits are affected by short-term fluctuations in the timing of payments and were comprised of the following:
| As of December 31, | ||
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Accrued salaries and wages | $68,704 | $64,960 |
| Accrued bonus | 30,356 | 26,502 |
| Accrued employee benefits | 77,470 | 75,456 |
| Total | $176,530 | $166,918 |
Other accrued liabilities
Other accrued liabilities were comprised of the following:
| As of December 31, | ||
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Contract liabilities | $109,424 | $98,674 |
| Payables from sale of accounts receivable | 49,919 | 71,691 |
| Contract and other reserves | 68,748 | 58,432 |
| Other | 38,948 | 32,938 |
| Total | $267,039 | $261,735 |
NOTE 9
DEBT
Senior Secured Credit Facilities
First Lien Credit Agreement
The First Lien Credit Agreement provides for senior secured first lien term loans in an aggregate principal amount of $1.2 billion, consisting of a $925.0 million term loan “B” tranche, (the First Lien Initial Term Tranche) and a $260.0 million incremental term loan “B” tranche (the First Lien Incremental Term Tranche and, together with the First Lien Initial Term Tranche, collectively, the First Lien Term Facility). On February 28, 2023, the outstanding balance of the First Lien Incremental Term Tranche of $258.7 million was repaid. The balance of unamortized deferred financing costs related to the First Lien Incremental Term Tranche of $11.9 million was recorded as a loss on extinguishment of debt in the Consolidated Statements of Income (Loss) for the year ended December 31, 2023.
On October 3, 2023, the First Lien Credit Agreement was amended to provide, among other things, a new tranche of term loans to replace or refinance in full all the existing term loans outstanding under the First Lien Initial Term Tranche, resulting in a loss on extinguishment of debt of $0.2 million in the Consolidated Statements of Income (Loss) for the year ended December 31, 2023.
On May 30, 2024, the First Lien Credit Agreement was amended to provide, among other things, a new tranche of term loans to replace or refinance in full all the existing term loans outstanding under the First Lien Initial Term Tranche, resulting in a loss on extinguishment of debt of $2.0 million in the Consolidated Statement of Income (Loss) for the year ended December 31, 2024.
On January 2, 2025, the First Lien Credit Agreement was amended to provide, among other things, a new tranche of term loans in an aggregate original principal amount of 899.8 million (the New Term Loans), in which the New Term Loans replace or refinance in full all the existing term loans outstanding under the First Lien Term Tranche in effect immediately prior to the amendment (the Existing Term Loans). The loans under the First Lien Credit Agreement, as amended (the First Lien Credit Agreement), amortize in an amount equal to approximately $2.2 million per quarter through September 30, 2030, with the balance of $848.0 million due on December 6, 2030. The replacement of the Existing Term Loans with the New Term Loans resulted in a loss on extinguishment of debt of $2.2 million in the Consolidated Statements of Income (Loss) for the year ended December 31, 2025.
V2X LLC (formerly known as Vertex Aerospace Services LLC) (V2X Borrower) obligations under the First Lien Credit Agreement are guaranteed by V2X Intermediate LLC (formerly known as Vertex Aerospace Intermediate LLC) and V2X Borrower’s wholly-owned domestic subsidiaries (collectively, the Guarantors), subject to customary exceptions and limitations. The V2X Borrower’s obligations under the First Lien Credit Agreement and the Guarantors’ obligations under the related guarantees are secured by a first priority lien on substantially all the V2X Borrower’s and the Guarantors’ assets which exists on a pari passu basis with the lien held by the 2023 Credit Agreement lenders.
The borrowings under the First Lien Credit Agreement bear interest at rates that, at the V2X Borrower’s option, can be either a base rate, determined by reference to the greater of (a) the federal funds rate plus 0.50%, (b) the prime lending rate, or (c) an adjusted Secured Overnight Financing Rate (SOFR) rate plus 1.00%, plus a margin of 1.25% per annum, or SOFR, plus a margin of 2.25% per annum. As of December 31, 2025, the effective interest rate for the First Lien Credit Agreement was 6.50%.
The First Lien Credit Agreement contains customary representations and warranties and affirmative covenants. The First Lien Credit Agreement also includes negative covenants that limit, among other things, additional indebtedness, additional liens, sales of assets, dividends, investments and advances, prepayments of debt and mergers and acquisitions.
The First Lien Credit Agreement contains customary events of default, including, but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, failure of any guaranty or security document supporting the First Lien Credit Agreement to be in full force and effect, and a change of control. If an event of default occurs and is continuing, the V2X Borrower may be required immediately to repay all amounts outstanding under the First Lien Credit Agreement.
As of December 31, 2025, the carrying value of the First Lien Credit Agreement was $890.8 million, excluding deferred discount and unamortized deferred financing costs of $23.9 million. The estimated fair value of the First Lien Credit Agreement as of December 31, 2025 was $896.3 million. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt (Level 2).
Second Lien Credit Agreement
The Second Lien Credit Agreement provided for senior secured second lien term loans in an aggregate principal amount of $185.0 million (the Second Lien Term Facility). On February 28, 2023, the remaining Second Lien Term Facility balance of $160.0 million was repaid (the 2023 Payoff) and related guarantees and liens were discharged and released. The balance of unamortized deferred financing costs related to the Second Lien Term Facility of $7.1 million was recorded as a loss on extinguishment of debt in the Consolidated Statements of Income (Loss) for the year ended December 31, 2023.
Under the terms of the Second Lien Credit Agreement, the V2X Borrower was required to remit a prepayment premium of $1.6 million with the 2023 Payoff, which was recorded as a loss on extinguishment of debt in the Consolidated Statements of Income (Loss) for the year ended December 31, 2023.
Vertex ABL Credit Agreement
The Vertex ABL Credit Agreement provided for a senior secured revolving loan facility (the ABL Facility) of up to an aggregate amount of $200.0 million (the loans thereunder, the ABL Loans). The Vertex ABL Credit Agreement also provided for (i) a $30.0 million sublimit of availability for letters of credit, and (ii) a $10.0 million sublimit for short-term borrowings on a swingline basis. On February 28, 2023, the outstanding ABL Facility borrowings of $67.5 million were repaid and related guarantees and liens were discharged and released. The balance of unamortized deferred financing costs related to the Vertex ABL Credit Agreement of $1.5 million was recorded as a loss on extinguishment of debt in the Consolidated Statements of Income (Loss) for the year ended December 31, 2023.
2023 Credit Agreement
On February 28, 2023, V2X Borrower entered into a credit agreement (the 2023 Credit Agreement) among the lenders identified therein and Bank of America, N.A., as administrative agent, collateral agent, swingline lender and letter of credit issuer. The 2023 Credit Agreement provides for $750.0 million in senior secured financing, with a first lien on substantially all the V2X Borrower’s assets and consists of (a) a $500.0 million five-year Revolving Credit Facility (2023 Revolver) (which includes (i) a $50.0 million sublimit of availability for letters of credit, and (ii) a $50.0 million sublimit for short-term borrowings on a swingline basis) and (b) afive-year $250.0 million Term Loan (2023 Term Loan). The proceeds of these Credit Facilities were used to, among other things, (i) repay the First Lien Incremental Term Tranche, (ii) repay the entire outstanding amount of the Second Lien Credit Agreement, and (iii) repay the entire outstanding ABL Credit Facility.
On March 31, 2025, the 2023 Credit Agreement was amended to provide, among other things, a new tranche of term loans in an aggregate original principal amount of $237.5 million (the 2025 Term Loans), which replace or refinance in full all the existing term loans outstanding under the 2023 Credit Agreement in effect immediately prior to the amendment. The 2023 Credit Agreement was further amended to provide a new tranche of revolving credit commitments in an aggregate original principal amount of $500.0 million (the 2025 Revolver), which replace or refinance in full all the existing revolving credit loans and commitments outstanding under the 2023 Credit Agreement in effect immediately prior to the amendment. The 2025 Term Loans amortize at approximately $1.5 million per quarter for the fiscal quarters ending June 30, 2025 through March 31, 2027, increasing to $3.0 million per quarter for the fiscal quarters ending June 30, 2027 through December 31, 2029, with the balance of $193.0 million due on March 31, 2030. The amendment to the 2023 Credit Agreement resulted in a loss on extinguishment of debt of $0.3 million in the Consolidated Statements of Income (Loss) for the year ended December 31, 2025.
The V2X Borrower’s obligations under the 2023 Credit Agreement are guaranteed by the Guarantors, subject to customary exceptions and limitations. The V2X Borrower’s obligations under the 2023 Credit Agreement and the Guarantors’ obligations under the related guarantees are secured by a first priority-lien on substantially all of the V2X Borrower’s and the Guarantors’ assets (subject to customary exceptions and limitations) which exists on a pari passu basis with the lien held by the First Lien Credit Agreement lenders.
The borrowings under the 2023 Credit Agreement bear interest at rates that, at the V2X Borrower’s option, can be either a base rate, determined by reference to the greater of (a) the federal funds rate plus 0.50%, (b) the prime lending rate, or (c) an adjusted SOFR rate plus 1.00%, plus a margin of 0.50% to 1.50% per annum, or SOFR, plus a margin of 1.50% to 2.50% per annum, in each case, depending on the consolidated total net leverage ratio of the V2X Borrower and its subsidiaries. As of December 31, 2025, the effective interest rate for the 2025 Term Loan was 5.89%.
Unutilized commitments under the 2025 Revolver are subject to a per annum fee ranging from 0.25% to 0.375% depending on the consolidated total net leverage ratio of the V2X Borrower and its subsidiaries.
The V2X Borrower is also required to pay a letter of credit fronting fee to each letter of credit issuer equal to 0.125% per annum of the amount available to be drawn under each such letter of credit (or such other amount as may be mutually agreed by the V2X Borrowers and the applicable letter of credit issuer), as well as a fee to all lenders equal to the applicable margin to SOFR of revolving credit loans times the average daily amount available to be drawn under all outstanding letters of credit.
The 2023 Credit Agreement contains customary representations and warranties, which must be accurate for the V2X Borrower to borrow under the 2023 Credit Agreement, and affirmative covenants. The 2023 Credit Agreement also includes negative covenants that limit, among other things, additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt, mergers and acquisitions.
The 2023 Credit Agreement contains financial covenants requiring (a) the consolidated total net leverage ratio not to exceed 5.00 to 1.00 for the reporting periods ending on or after June 30, 2023, and on or prior to June 30, 2024, with a step down to 4.75 to 1.00 for periods ending on or after July 1, 2024, and on or prior to December 31, 2025, with further step downs thereafter, and (b) the consolidated interest coverage ratio be at least 2.00 to 1.00 commencing with the reporting period ending on June 30, 2023.
The 2023 Credit Agreement contains customary events of default, including, but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, failure of any guaranty or security document supporting the 2023 Credit Agreement to be in full force and effect, and a change of control. If an event of default occurs and is continuing, the V2X Borrower may be required immediately to repay all amounts outstanding under the 2023 Credit Agreement.
As of December 31, 2025, there wereno outstanding borrowings and $21.5 million of outstanding letters of credit under the 2025 Revolver. Availability under the 2025 Revolver was $478.5 million as of December 31, 2025. Unamortized deferred financing costs related to the 2025 Revolver of $4.0 million are included in other non-current assets in the Consolidated Balance Sheets as of December 31, 2025. As of December 31, 2025, the fair value of the 2025 Revolver approximated the carrying value because the debt bears a floating interest rate.
As of December 31, 2025, the carrying value of the 2025 Term Loans was $233.0 million, excluding unamortized deferred financing costs of $1.7 million. The estimated fair value of the 2025 Term Loans as of December 31, 2025 was $233.9 million. The fair value is based on observable inputs of interest rates that are currently available to us for debt with similar terms and maturities for non-public debt (Level 2).
The aggregate scheduled maturities of the First Lien Credit Agreement and 2023 Credit Agreement as of December 31, 2025 are as follows:
| (In thousands) | Payments due |
|---|---|
| 2026 | $14,935 |
| 2027 | 19,388 |
| 2028 | 20,873 |
| 2029 | 20,873 |
| 2030 | 1,047,750 |
| Total | $1,123,819 |
As of December 31, 2025, the Company was in compliance with all covenants related to the First Lien Credit Agreement and the 2023 Credit Agreement.
NOTE 10
DERIVATIVE INSTRUMENTS
Interest Rate Derivative Instruments
The Company is exposed to the risk that earnings and cash flows could be adversely impacted due to fluctuations in interest rates. To mitigate this risk, the Company has periodically entered into interest rate swaps in which we agree to exchange, at specified intervals, the difference between variable and fixed interest amounts calculated by reference to an agreed-upon notional amount. Derivative instruments are not used for trading purposes or to manage exposure to changes in interest rates for investment securities. The Company's outstanding derivative instruments have not contained credit risk related contingent features nor is collateral generally required.
The interest rate swaps are measured at fair value on a recurring basis and are determined using the income approach based on a discounted cash flow model to determine the present value of future cash flows over the remaining term of the contract incorporating observable market inputs such as prevailing interest rates as of the reporting date (Level 2). Changes in fair value of the interest rate swap are recorded, net of tax, as a component of accumulated other comprehensive loss in the accompanying Consolidated Balance Sheets. The Company reclassifies the effective gain or loss from accumulated other comprehensive loss, net of tax, to interest expense on the Consolidated Statements of Income (Loss) as the interest expense is recognized on the related debt. The ineffective portion of the change in fair value of the interest rate swap, if any, is recognized directly in earnings in interest expense.
The Company has entered into$450.0 million of interest rate swap contracts as of December 31, 2025. As of December 31, 2025 and 2024, these contracts had notional values of $428.1 million and$439.1 million, respectively. These contracts are designated and qualify as effective cash flow hedges.
The following table summarizes the amount at fair value and location of the derivative instruments for interest rate hedges in the Consolidated Balance Sheets:
| Fair Value (level 2) | |||
|---|---|---|---|
| As of | |||
| December 31, · December 31, | |||
| (In thousands) | Balance sheet caption | 2025 | 2024 |
| Interest rate swap designated as cash flow hedge | Prepaid expenses and other current assets | $— | $1,918 |
| Interest rate swap designated as cash flow hedge | Other non-current assets | $— | $1,938 |
| Interest rate swap designated as cash flow hedge | Other accrued liabilities | $770 | $— |
| Interest rate swap designated as cash flow hedge | Other non-current liabilities | $1,380 | $— |
| Interest rate swap designated as cash flow hedge | Accumulated other comprehensive loss | $(2,150) | $3,856 |
The Company regularly assesses the creditworthiness of the counterparty. As of December 31, 2025, the counterparty to the interest rate swaps had performed in accordance with its contractual obligations. Both the counterparty credit risk and the Company's credit risk were considered in the fair value determination.
Net interest rate derivative gains of $2.6 million, $5.7 million, and $4.1 million were recognized in interest expense, net in the Consolidated Statements of Income (Loss) during 2025, 2024, and 2023, respectively. The Company expects $0.8 million of existing interest rate swap expense reported in accumulated other comprehensive loss as of December 31, 2025 to be recognized in earnings within the next 12 months.
NOTE 11
LEASES
We determine whether an arrangement contains a lease at inception. We have operating leases for office space, apartments, vehicles, and machinery and equipment. Our operating leases have lease terms of less thanone year toten years. Finance leases are not considered significant to our Consolidated Balance Sheets, Consolidated Statements of Income (Loss), or Consolidated Statements of Cash Flows.
We do not separate lease components from non-lease components (e.g., common area maintenance, property taxes, and insurance) but account for both components in a contract as a single lease component.
The components of lease expense are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Operating | $11,591 | $15,501 | $20,064 |
| Variable | 655 | 640 | 348 |
| Short-term and other | 105,079 | 107,650 | 85,345 |
| Sublease income | (848) | (805) | (81) |
| Total lease expense | $116,477 | $122,986 | $105,676 |
Supplemental balance sheet information related to our operating leases is as follows:
| As of December 31, | ||
|---|---|---|
| (In thousands) | 2025 | 2024 |
| Right-of-use assets (recorded in other non-current assets) | $29,255 | $37,448 |
| Current lease liabilities (recorded in other accrued liabilities) | $10,784 | $10,968 |
| Long-term lease liabilities (recorded in other non-current liabilities) | 30,416 | 33,728 |
| Total lease liabilities | $41,200 | $44,696 |
During the year ended December 31, 2025, we recognized additional right-of-use assets of $10.2 million from newly executed operating leases.
The weighted average remaining lease term and discount rate for our operating leases as of December 31, 2025 were 4.50 years and 5.3%, respectively.
Maturities of operating lease liabilities as of December 31, 2025 were as follows:
| (In thousands) | Payments due |
|---|---|
| 2026 | $12,599 |
| 2027 | 10,749 |
| 2028 | 7,970 |
| 2029 | 6,208 |
| 2030 | 4,166 |
| After 2030 | 4,350 |
| Total minimum lease payments | $46,042 |
| Less: Imputed interest | (4,842) |
| Total lease liabilities | $41,200 |
NOTE 12
INCOME TAXES
The Company determines the provision for income taxes using the asset and liability approach. Under this approach, deferred income taxes represent the expected future tax consequences of temporary differences between the carrying amounts and tax basis of assets and liabilities. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. In assessing the need for a valuation allowance, the Company looks to the future reversal of existing taxable temporary differences, taxable income in carryback years, the feasibility of tax planning strategies and estimated future taxable income. The valuation allowance can be affected by changes to tax laws, changes to statutory tax rates and changes to future taxable income estimates. For the year ended December 31, 2025, the Company did not establish or release an additional valuation allowance.
The sources of pre-tax income and the components of income tax expense (benefit) are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 |
| Income components | |||
| United States | $84,378 | $31,024 | $(32,143) |
| Foreign | 16,525 | 7,817 | 7,625 |
| Total pre-tax income (loss) | $100,903 | $38,841 | $(24,518) |
| Income tax expense (benefit) components | |||
| Current income tax expense (benefit) | |||
| United States-Federal | $(130) | $(10,015) | $(3,776) |
| United States-State and local | 1,531 | (1,207) | 1,648 |
| Foreign | 12,286 | 7,168 | 7,208 |
| Total current income tax expense (benefit) | 13,687 | (4,054) | 5,080 |
| Deferred income tax expense (benefit) | |||
| United States-Federal | 7,577 | 7,849 | (7,368) |
| United States-State and local | 1,943 | 2,394 | 747 |
| Foreign | (186) | (2,032) | (404) |
| Total deferred income tax expense (benefit) | 9,334 | 8,211 | (7,025) |
| Total income tax expense (benefit) | $23,021 | $4,157 | $(1,945) |
| Effective income tax rate | 22.8% | 10.7% | 7.9% |
The following table shows the principal reasons for the difference between the effective income tax rate and the statutory federal income tax rate:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| (In thousands, except percent data) | Amount | Percent | Amount | Percent | Amount | Percent |
| Tax provision at U.S. statutory rate | $21,190 | 21.0% | $8,157 | 21.0% | $(5,149) | 21.0% |
| State and local income tax, net of federal income tax effect1 | 2,550 | 2.5% | 1,422 | 3.7% | 1,892 | (7.7)% |
| Foreign tax effects | ||||||
| Germany | ||||||
| Statutory tax rate difference between Germany and United States | 1,101 | 1.1% | 174 | 0.4% | 499 | (2.0)% |
| Other countries | 967 | 1.0% | (492) | (1.3)% | 376 | (1.5)% |
| Effects of cross-border tax laws | ||||||
| GILTI, net of GILTI Foreign Tax Credits | (309) | (0.3)% | 780 | 2.0% | 252 | (1.0)% |
| Tax Credits | ||||||
| Research and Development Credit | 66 | 0.1% | 324 | 0.8% | (1,310) | 5.3% |
| Work Opportunity Tax Credit | (643) | (0.6)% | (1,482) | (3.8)% | (1,246) | 5.1% |
| Nontaxable or Nondeductible items | ||||||
| Non-deductible compensation expense | 806 | 0.8% | 2,392 | 6.2% | 1,957 | (8.0)% |
| Transaction cost amortization | — | —% | — | —% | 2,799 | (11.4)% |
| Foreign derived intangible income deduction | (542) | (0.5)% | — | —% | (266) | 1.1% |
| Dividend received deduction | (739) | (0.7)% | (2,282) | (5.9)% | — | —% |
| Unrealized loss (gain) | 675 | 0.7% | (659) | (1.7)% | 189 | (0.8)% |
| Meals and entertainment | 14 | —% | (448) | (1.2)% | 494 | (2.0)% |
| Tax on gain from acquisitions | — | —% | (664) | (1.7)% | — | —% |
| Other | 226 | —% | (61) | (0.1)% | (411) | 1.6% |
| Changes in Unrecognized Tax Benefits | ||||||
| Uncertain tax positions | (2,341) | (2.3)% | (3,004) | (7.7)% | (2,021) | 8.2% |
| Effective income tax rate | $23,021 | 22.8% | $4,157 | 10.7% | $(1,945) | 7.9% |
| 1State taxes in California, Maryland, Texas and Virginia made up the majority (greater than 50%) of the tax effect in this category | ||||||
The effective income tax rate for the year ended December 31, 2025 was 22.8% compared to 10.7% for the year ended December 31, 2024. The increase in the effective income tax rate was primarily due to an increase in foreign taxes, decrease in tax credits, non-deductible expenses, nontaxable income and release of uncertain tax positions.
The effective income tax rate for the year ended December 31, 2024 was 10.7% compared to 7.9% for the year ended December 31, 2023. The increase in the effective income tax rate was primarily due to an increase in pre-tax book income, GILTI, decreases in non-deductible expenses, and research and development expenditures, partially offset by increases in nontaxable income.
The amount of income taxes paid, net of amounts refunded are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 |
| Federal | $— | $758 | $1,300 |
| State | |||
| California | 146 | 558 | 249 |
| Maryland | 105 | 483 | 168 |
| Texas | 837 | 596 | 487 |
| Other states | (630) | 1,821 | 1,641 |
| Foreign | |||
| Canada | 1,189 | 320 | — |
| Germany | 1,872 | 2,765 | 2,215 |
| Iraq | 560 | 553 | 907 |
| Saudi Arabia | 5,043 | — | — |
| Other countries | 510 | 965 | 1,389 |
| Total income taxes paid, net of amounts refunded | $9,632 | $8,819 | $8,356 |
Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities, applying enacted tax rates in effect for the year in which the Company expects the differences will reverse. Deferred tax assets and liabilities include the following:
| As of December 31, | ||
|---|---|---|
| (in thousands) | 2025 | 2024 |
| Deferred tax assets | ||
| Compensation and benefits | $14,820 | $12,371 |
| Reserves | 23,343 | 23,208 |
| Lease liability | 9,941 | 10,477 |
| Research expenditures | — | 14,092 |
| Tax credits | 14,447 | 7,951 |
| Disallowed interest | 39,802 | 49,229 |
| Net operating losses | 2,909 | 2,724 |
| Other | 3,386 | 3,967 |
| Total deferred tax assets | $108,648 | $124,019 |
| Deferred tax liabilities | ||
| Goodwill and intangibles | $(96,962) | $(97,225) |
| Unbilled receivables | (19,715) | (22,229) |
| Property, plant and equipment, net | (5,799) | (7,888) |
| Right-of-use assets | (7,217) | (8,775) |
| Other liabilities | (7,312) | (8,885) |
| Total deferred tax liabilities | (137,005) | (145,002) |
| Net deferred tax liabilities | $(28,357) | $(20,983) |
Uncertain Tax Positions
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 |
| Unrecognized tax benefits-January 1, | $3,577 | $6,593 | $8,611 |
| Additions for: | |||
| Current year tax positions | — | — | 517 |
| Prior year tax positions | — | — | 28 |
| Reductions for: | |||
| Lapse of statute of limitations | (2,329) | (3,016) | (2,563) |
| Unrecognized tax benefits-December 31, | $1,248 | $3,577 | $6,593 |
As of December 31, 2025, 2024, and 2023, unrecognized tax benefits from uncertain tax positions were $1.2 million, $3.6 million and $6.6 million, respectively. It is reasonably possible that the Company's total unrecognized tax benefits will decrease by approximately $1.0 million during the next 12 months in connection with matters which may be resolved. The total amount of unrecognized benefit that, if recognized, would affect the effective tax rate was $1.6 million, $4.1 million, and $7.1 million as of December 31, 2025, 2024, and 2023, respectively, excluding the interest and penalties.
Interest relating to tax matters is classified as a component of interest expense and tax penalties as a component of income tax expense on the Consolidated Statements of Income (Loss). The Company recognized net interest including interest related to released reserves to tax matters of $(0.4) million, $(0.2) million, and $0.2 million during the years ended December 31, 2025, 2024 and 2023, respectively. The Company has accrued $(0.5) million and $(0.2) million of net interest and penalties as of December 31, 2025 and 2024, respectively.
The Company has not recorded a deferred tax liability for undistributed earnings of certain foreign subsidiaries since such earnings are considered to be reinvested indefinitely. If the earnings were distributed, the Company may be subject to federal income and foreign withholding taxes.
The Company files income tax returns in the U.S. and in various foreign jurisdictions. The Company is no longer subject to U.S. federal or state income tax examinations for years prior to 2022. Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (i) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the period cost method) or (ii) factoring such amounts into a measurement of its deferred taxes (the deferred method). The Company has chosen to account for GILTI under the period cost method as an accounting policy, and therefore the anticipated future expense associated with GILTI is not reflected in the Consolidated Financial Statements.
Other
The One Big Beautiful Bill Act (OBBBA) was enacted on July 4, 2025. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research expensing and increases the business interest expense limitation. The Company expects to accelerate certain deductions post-enactment in 2025 and later years to minimize cash tax payments.
NOTE 13
POST-EMPLOYMENT BENEFIT PLANS
We sponsorone defined contribution savings plan, which allows employees to contribute a portion of their pre-tax and/or after-tax income in accordance with specified guidelines. The Company's contributions to this plan charged to income amounted to $35.0 million, $35.0 million and $30.3 million for the years ended December 31, 2025, 2024 and 2023, respectively.
The Company participates in, but does not sponsor, multiemployer pension plans for certain employees covered by collective bargaining agreements who perform work on contracts within the continental U.S. Contributions are based on specified hourly rates for eligible hours. Company expenses related to these plans were $18.8 million, $18.1 million and $12.9 million for the years ended December 31, 2025, 2024, and 2023, respectively. The Company is unaware of any significant future obligations or funding requirements related to these plans other than the ongoing contributions that are paid as hours are worked by plan participants. None of these multiemployer pension plans are individually significant to the Company.
The Company sponsors non-qualified deferred compensation plans, under which participants are eligible to defer a portion of their compensation on a tax deferred basis. The assets in the plan are held in a Rabbi trust. Plan investments and obligations were recorded in other non-current assets and other non-current liabilities, respectively, in the Consolidated Balance Sheets, representing the fair value related to the deferred compensation plans. Adjustments to the fair value of plan investments and obligations are recorded in selling, general, and administrative expenses. The plan assets and liabilities as of December 31, 2025 and 2024 were $5.8 million and $5.2 million, respectively.
The Company has an amended and restated the Senior Executive Severance Pay Plan (the Amended Plan) that has been effective since 2016. Termination benefits offered under the Amended Plan are other post-employment benefits as defined by ASC Topic 712 Compensation - Nonretirement Postemployment Benefits. Benefits under the Amended Plan vest or accumulate with the employee’s years of service; however, the payment of benefits is not probable, and the Company does not have the ability to reliably estimate when there will be an involuntary termination without cause under the Amended Plan. Accordingly, the Company does not accrue a benefit obligation for severance costs under the Amended Plan over the duration of executive employment.
NOTE 14
COMMITMENTS AND CONTINGENCIES
General
From time to time, the Company is involved in various investigations, lawsuits, arbitrations, claims, enforcement actions and other legal proceedings, including government investigations and claims, which are incidental to the operation of its business. Some of these proceedings seek remedies relating to employment matters, matters relating to injuries to people or property damage, matters in connection with the Company's contracts and matters arising under laws relating to the protection of the environment. Additionally, U.S. government customers periodically advise the Company of claims and penalties concerning certain potential disallowed costs. When such findings are presented, V2X and the U.S. government representatives engage in discussions to enable V2X to evaluate the merits of these claims as well as to assess the amounts being claimed.
Where appropriate, provisions are made to reflect probable losses related to the matters raised by U.S. government representatives. Such assessments, along with any assessments regarding provisions for other legal proceedings, are reviewed on a quarterly basis for sufficiency based on the latest information available to us.
The Company estimated and accrued $14.4 millionand $13.1 million as of December 31, 2025 and 2024, respectively, in other accrued liabilities in the Consolidated Balance Sheets for legal proceedings and for claims with respect to its U.S. government contracts as discussed below, including years where the U.S. government has not completed its incurred cost audits. Although the ultimate outcome of any legal matter or claim cannot be predicted with certainty, based on present information, including the assessment of the merits of a particular claim, the Company does not expect that any asserted or unasserted legal or contractual claims or proceedings, individually or in the aggregate, will have a material adverse effect on its cash flows, results of operations or financial condition.
U.S. Government Contracts, Investigations and Claims
The Company has U.S. government contracts that are funded incrementally on a year-to-year basis. Changes in government policies, priorities or funding levels through agency or program budget reductions by the U.S. Congress or executive agencies could have a material adverse effect on the Company’s financial condition or results of operations. Furthermore, the Company's contracts with the U.S. government may be terminated or suspended by the U.S. government at any time, with or without cause. Such contract suspensions or terminations could result in non-reimbursable expenses or charges or otherwise adversely affecting the Company's financial condition and results of operations.
Departments and agencies of the U.S. government have the authority to investigate various transactions and operations of the Company, and the results of such investigations may lead to administrative, civil or criminal proceedings, the ultimate outcome of which could be fines, penalties, repayments or compensatory or treble damages. U.S. government regulations provide that certain findings against a contractor may lead to suspension or debarment from future U.S. government contracts or the loss of export privileges for a company or an operating division or subdivision. Suspension or debarment could have a material adverse effect on the Company because of its reliance on U.S. government contracts.
U.S. government agencies, including the DCAA, the DCMA and others, routinely audit and reviewthe Company's performance on government contracts, indirect rates and pricing practices, and compliance with applicable contracting and procurement laws, regulations and standards. Accordingly, costs billed or billable to U.S. government customers are subject to potential adjustment upon audit by such agencies. The U.S. government agencies also review the adequacy of compliance with government standards for business systems, including accounting, earned value management, estimating, materials management and accounting, purchasing, and property management systems. A finding by a U.S. government agency that the Company's business systems are not adequate could adversely affect the Company's financial condition and results of operations.
In the performance of its contracts, the Company routinely requests contract modifications that require additional funding from U.S. government customers. Most often, these requests are due to customer-directed changes in the scope of work. Whilethe Company isentitled to recovery of these costs under its contracts, the administrative process with the U.S. government customer may be protracted. Based on the circumstances, the Company periodically files REAs that are sometimes converted into claims. In some cases, these requests are disputed by the U.S. government customer. The Company believes itsoutstanding modifications, REAs and other claims will be resolved without material adverse impact to its results of operations, financial condition or cash flows.
NOTE 15
STOCK-BASED COMPENSATION
The Company maintains an equity incentive plan, the 2014 Omnibus Incentive Plan, as amended and restated effective as of May 8, 2025 (the 2014 Omnibus Plan), to govern awards granted to V2X employees and directors, including nonqualified stock options (NQOs), restricted stock units (RSUs), performance share units (PSUs) and other awards. The Company accounts for NQOs, stock-settled RSUs and PSUs as equity-based compensation awards.
There were 4.4 million shares of the Company's common stock authorized for issuance under the 2014 Omnibus Plan. As of December 31, 2025,1.3 million shares remained available for future awards.
Stock-based compensation expense and the associated tax benefits impacting our Consolidated Statements of Income (Loss) were as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Compensation costs for equity-based awards | $11,924 | $15,383 | $31,456 |
| Compensation costs for other awards | — | 586 | 1,387 |
| Total compensation costs, pre-tax | $11,924 | $15,969 | $32,843 |
| Future tax benefit | $2,757 | $3,710 | $7,685 |
At December 31, 2025, total unrecognized compensation costs related to equity-based awards were $17.1 million, which are expected to be recognized ratably over a weighted average period of 1.66 years.
Non-Qualified Stock Options
NQOs vest in one-third increments on the first, second and third anniversaries of the grant date and expire 10 years from the date of grant.
A summary of the status of our NQOs as of December 31, 2025, 2024 and 2023 and changes during the years then ended is presented below:
| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| (In thousands, except per share data) | Shares | Weighted Average Exercise Price Per Share | Shares | Weighted Average Exercise Price Per Share | Shares | Weighted Average Exercise Price Per Share |
| Outstanding at January 1, | 34 | $22.43 | 40 | $22.93 | 42 | $22.86 |
| Exercised | (24) | $22.96 | (6) | $25.90 | (2) | $20.62 |
| Outstanding and exercisable at December 31, | 10 | $21.19 | 34 | $22.43 | 40 | $22.93 |
All outstanding NQOs are exercisable. The following table summarizes information about NQOs outstanding and exercisable as of December 31, 2025:
| (In thousands, except per share data) · Options Outstanding and Exercisable | ||||
|---|---|---|---|---|
| Range of Exercise Prices Per Share | Number | Weighted Average Remaining Contractual Life (In Years) | Weighted Average Exercise Price Per Share | Aggregate Intrinsic Value |
| $20.06 - $21.98 | 10 | 0.76 | $21.19 | $345 |
| Total options and aggregate intrinsic value | 10 | 0.76 | $21.19 | $345 |
The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on our closing stock price of $54.55 per share on December 31, 2025, which would have been received by the option holders if all option holders had exercised their options as of that date. There were no exercisable options "out of the money" as of December 31, 2025. The aggregate intrinsic value of options exercised during the years ended December 31, 2025 was $0.8 million. The aggregate intrinsic value of options exercised during both of the years ending December 31, 2024 and 2023 wasnot material.
Restricted Stock Units
RSUs awarded to employees typically vest in one-third increments on each of the three anniversary dates following the grant date subject to continued employment as described in the RSU award agreement. RSUs issued to directors are typically granted annually and vest approximatelyone year after the grant date. The fair value of each RSU grant was determined based on the closing price of V2X common stock on the date of grant. Stock compensation expense will be recognized ratably over the requisite service period of the RSU awards. RSUs have no voting rights and, if an employee leaves the Company prior to vesting, whether through resignation or termination for cause, the RSUs are typically forfeited. If an employee retires or is terminated by the Company other than for cause, all or a pro rata portion of the RSUs may vest.
The table below provides a roll-forward of outstanding RSUs for the years ended December 31, 2025, 2024 and 2023.
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| (In thousands, except per share data) | Shares | Weighted Average Grant Date Fair Value Per Share | Shares | Weighted Average Grant Date Fair Value Per Share | Shares | Weighted Average Grant Date Fair Value Per Share |
| Outstanding at January 1, | 436 | $43.11 | 800 | $37.29 | 1,628 | $35.47 |
| Granted | 264 | $49.28 | 317 | $45.58 | 318 | $40.50 |
| Vested | (216) | $42.18 | (549) | $37.35 | (1,136) | $43.07 |
| Forfeited or canceled | (76) | $46.54 | (132) | $42.62 | (10) | $42.81 |
| Outstanding at December 31, | 408 | $46.96 | 436 | $43.11 | 800 | $37.29 |
The total grant date fair value of RSUs that vested during the years ended December 31, 2025, 2024 and 2023 was $9.1 million,$20.5 million and $40.0 million, respectively.
As of December 31, 2025, there was $10.3 million of unrecognized RSU related compensation expense.
Performance Share Units
During the year ended December 31, 2023, the Company grantedtwo types of performance-based awards with market conditions. The first award will vest and the stock will be issued at the end of athree-year period assuming and based on i) the attainment of total shareholder return performance measures relative to certain Aerospace and Defense companies in the S&P 1500 Index and ii) the employee's continued service through the vesting date. The number of shares ultimately awarded, if any, can range up to 200% of the specified target awards. If performance is below the threshold level of performance, no shares will be issued. The second award will vest and stock will be issued at the end of a three-year period assuming and based on i) achievement of certain stock price targets, ii) shareholder return performance measures relative to certain Aerospace and Defense companies in the S&P 1500 Index and iii) the employee's continued service through the vesting date. The numbers of shares ultimately awarded, if any, can range up to the specified target awards.
During the year ended December 31, 2024, the Company granted performance-based awards that will vest and stock will be issued at the end of athree-year period assuming and based on i) the attainment of total shareholder return performance measures relative certain to Aerospace and Defense companies in the S&P 1500 Index and ii) the employee's continued service through the vesting date. The number of shares ultimately awarded, if any, can range up to 200% of the specified target awards. If performance is below the threshold level of performance, no shares will be issued.
During the year ended December 31, 2025, the Company granted performance-based awards that includetwo performance components, including total shareholder return performance and Adjusted Earnings Per Share performance. The performance-based awards will vest and the stock will be issued at the end of athree-year period assuming and based on i) the attainment of total shareholder return performance measures relative to certain Aerospace and Defense companies in the S&P 1500 Index, ii) Company performance against an annual adjusted EPS target established each year and iii) the employee's continued service through the vesting date. The number of shares ultimately awarded, if any, can range up to 200% of the specified target awards. If performance is below the threshold level of performance, no shares will be issued. A Monte Carlo valuation model was used to determine the fair value of the awards by simulating 50,000 potential TSR outcomes for the Company and a group of peer companies over the performance periods, and determined the amount of the payout that would occur in each simulation. The fair value is based on the average of the results.
The table below provides a roll-forward of outstanding PSUs for the years ended December 31, 2025, 2024 and 2023.
| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| (In thousands, except per share data) | Shares | Weighted Average Grant Date Fair Value Per Share | Shares | Weighted Average Grant Date Fair Value Per Share | Shares | Weighted Average Grant Date Fair Value Per Share |
| Outstanding at January 1, | 258 | $43.98 | 267 | $43.45 | — | $— |
| Granted | 139 | $53.66 | 161 | $45.44 | 279 | $40.41 |
| Forfeited or canceled | (29) | $33.53 | (170) | $36.27 | (12) | $51.38 |
| Outstanding at December 31, | 368 | $48.48 | 258 | $43.98 | 267 | $43.45 |
As of December 31, 2025, there was $6.8 million of unrecognized PSU related compensation expense.
NOTE 16
SHAREHOLDERS' EQUITY
As of December 31, 2025, our authorized capital was comprised of 100.0 million shares of common stock and 10.0 million shares of preferred stock. As of December 31, 2025, there were 31.7 million shares of common stock issued and 31.2 million shares of common stock outstanding.
We issue shares of our common stock in connection with our 2014 Omnibus Plan. There were 4.4 million shares of common stock authorized under this plan. As of December 31, 2025, we had a remaining balance of 1.3 million shares of common stock available for future grants under this plan. Any shares related to awards that terminate by expiration, forfeiture, cancellation, or otherwise without the issuance of shares, are settled in cash in lieu of shares or are exchanged with the Committee's permission for awards not involving shares and are available again for grant under the 2014 Omnibus Plan.
Share Repurchases
On May 12, 2025, the Company announced that its Board authorized the repurchase of up to $100.0 million of the Company's common stock subject to certain conditions, in the open market, in block purchases, or in privately negotiated transactions, with the authorization expiring on May 12, 2028. As of December 31, 2025, the Company has repurchased 563,638 shares for an aggregate amount of $30.3 million, including excise taxes and other direct costs. Shares repurchased for purposes other than retirement are accounted for as treasury stock and are recorded as a reduction of shareholders' equity on the Company's Consolidated Balance Sheet.
NOTE 17
SALE OF RECEIVABLES
The Company has a Master Accounts Receivable Purchase Agreement (MARPA Facility) with MUFG Bank, Ltd. (MUFG) for the sale of certain designated eligible receivables up to a maximum amount of $400.0 million with the U.S. government. Receivables sold under the MARPA Facility are without recourse for any U.S. government credit risk.
The Company accounts for these receivable transfers under the MARPA Facility as sales under ASC Topic 860, Transfers and Servicing, and removes the sold receivables from its balance sheet. The fair value of the sold receivables approximated their book value due to their short-term nature.
| As of and for the | |||
|---|---|---|---|
| Year Ended December 31, | |||
| (In thousands) | 2025 | 2024 | 2023 |
| Beginning balance: | $218,897 | $72,714 | $— |
| Sale of receivables | 3,496,285 | 3,195,217 | 1,394,998 |
| Cash collections | (3,438,462) | (3,049,034) | (1,322,284) |
| Outstanding balance sold to MUFG1 | 276,720 | 218,897 | 72,714 |
| Cash collected, not remitted to MUFG2 | (49,768) | (71,457) | (10,160) |
| Remaining sold receivables | $226,952 | $147,440 | $62,554 |
| 1 For the year ended December 31, 2025, the Company recorded a net cash inflow, excluding fees, from sale of receivables of $57.8 million from operating activities. | |||
| 2 Includes the cash collected on behalf of, but not yet remitted to, MUFG as of December 31, 2025. This balance is included in other accrued liabilities as of the balance sheet date. | |||
For the years ended December 31, 2025, 2024, and 2023 the Company incurred purchase discount fees, net of servicing fees, of $11.2 million, $10.5 million, and $4.0 million which are presented in other expense, net on the Consolidated Statements of Income (Loss) and are reflected as cash flows from operating activities on the Consolidated Statements of Cash Flows.
The Company does not retain an ongoing financial interest in the transferred receivables other than cash collection and administrative services. The Company estimated that its servicing fee was at fair value and therefore has not recognized a servicing asset or liability as of December 31, 2025. Proceeds from the sale of receivables are reflected as cash inflows from operating activities on the Consolidated Statements of Cash Flows.
NOTE 18
SEGMENT INFORMATION
The Company operates as a single reportable segment. V2X performs services worldwide, with the substantial majority of revenue derived from the U.S. government. The CODM for the Company is the President and Chief Executive Officer. The CODM uses consolidated profit metrics, including net income (loss) and operating income, as reported on the Consolidated Statements of Income (Loss), to allocate resources and assess financial performance.
Our CODM reviews significant expenses as reported in the Consolidated Statements of Income (Loss) in addition to depreciation and amortization information, which is summarized below for the years ended December 31, 2025, 2024, and 2023:
| Year Ended December 31, | |||
|---|---|---|---|
| (In thousands) | 2025 | 2024 | 2023 |
| Depreciation and amortization | $112,524 | $114,882 | $113,311 |
The CODM also reviews consolidated capital expenditures as reported as purchases of capital assets and intangibles in the Consolidated Statements of Cash Flows.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.